Author(s)

Ping Gui, Xiaotao Wang

Corresponding Author

Xiaotao Wang

Abstract

The paper is to observe the application of salmon calcitonin to the curing of chronic obstructive pulmonary disease (COPD) with osteoporosis and evaluate its clinical effect. 90 patients suffering COPD with osteoporosis who were admitted by the Renmin Hospital from March, 2015 to June, 2017 are taken as the research objects; they are divided into two groups according to the filing sequence, control group and research group with 45 respective patients; give conventional therapy was given to the control group, and salmon calcitonin on the basis of conventional therapy was for the research group; the treatment periods of both groups were 8 weeks. Finally, the paper summarizes and compares the treatment effect of in the two groups. Results show that, before treatment, the differences of patients in the two groups in the bone mineral density of lumbar vertebra (L2~4), ostealgia grading and pulmonary function grading had no statistical significance (P>0.05); but after treatment, all of them were improved (P<0.05), and the improvement effect in the research group was better than that in the control group obviously (P<0.05). Thus, the curative effect to apply salmon calcitonin to the treatment of COPD with osteoporosis was satisfactory, so salmon calcitonin was helpful to improve patients’ bone mineral density and pulmonary function and ease ostealgia with important practical value.

Keywords

Salmon calcitonin, chronic obstructive pulmonary disease (COPD), osteoporosis, curative effect.